Media Summary: Dr. Fadi Haddad from The University of Texas MD Anderson Cancer Center addresses current Paul Koller, MD, Assistant Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City ... Nikolai Podoltsev, MD, PhD, is an associate professor in the section for Medical Oncology and Hematology in the Department of ...

Cml Treatment Advances 2026 - Detailed Analysis & Overview

Dr. Fadi Haddad from The University of Texas MD Anderson Cancer Center addresses current Paul Koller, MD, Assistant Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City ... Nikolai Podoltsev, MD, PhD, is an associate professor in the section for Medical Oncology and Hematology in the Department of ... Jorge Cortes, MD, Georgia Cancer Center, Augusta University, Augusta, GA, discusses the evolution of Jorge Cortes, MD, Georgia Cancer Center, Augusta University, Augusta, GA, discusses exciting In this segment, Dr. Andreas Hochhaus, a leading expert in oncology and

Simona Soverini, PhD, stopped by the Society of Hematologic Oncology booth at the 64th American Society of Hematology ... Medical Centric Recommended : (Affiliate Links) Thermometer ➝ Blood pressure machine ... In this webinar, Dr. Jeff Lipton, from the University of Toronto, Canada, Dr. Hemant Malhotra, from Sri Ram Cancer and ... Gianantonio Rosti, MD, Institute of Hematology 'Seragnoli', Bologna, Italy, discusses the current landscape of Professor Mhairi Copland Professor of Translational Haematology University of Glasgow, UK 00:00 Welcome & Introduction 01:21 ... In this exclusive interview, Dr. Elias Jabbour from MD Anderson Cancer Center shares cutting-edge insights into the evolving ...

Earn CME for related activities: In this webcast from the ' Dr. Shah on Frontline Considerations for the Treatment of CML

Photo Gallery

CML: Treatment Advances 2026
How I treat CML in 2026
Chronic Myeloid Leukemia: Advancements in Treatment
CML Management: What Goals Can Clinicians Achieve With Current Treatments?
Treatment Options for Chronic Myeloid Leukemia (CML) -
The evolution of treatment goals in CML: beyond survival outcomes
Advancements in CML: improving treatment-free remission and novel agents
CML: Treatment and Side Effects Tips
The Evolution of CML Treatment and the Push for Better Tolerability – Dr. Andreas Hochhaus
Simona Soverini, PhD, on CML Treatment Advances, Remaining Challenges
Chronic Myeloid Leukemia: Breakthrough Therapies You Should Know
Global Perspectives | Evolution of CML Treatment and Managing Adverse Events
View Detailed Profile
CML: Treatment Advances 2026

CML: Treatment Advances 2026

Dr. Fadi Haddad from The University of Texas MD Anderson Cancer Center addresses current

How I treat CML in 2026

How I treat CML in 2026

Wednesday, February 11,

Chronic Myeloid Leukemia: Advancements in Treatment

Chronic Myeloid Leukemia: Advancements in Treatment

Paul Koller, MD, Assistant Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City ...

CML Management: What Goals Can Clinicians Achieve With Current Treatments?

CML Management: What Goals Can Clinicians Achieve With Current Treatments?

Nikolai Podoltsev, MD, PhD, is an associate professor in the section for Medical Oncology and Hematology in the Department of ...

Treatment Options for Chronic Myeloid Leukemia (CML) -

Treatment Options for Chronic Myeloid Leukemia (CML) -

Hearing you or someone you love has

The evolution of treatment goals in CML: beyond survival outcomes

The evolution of treatment goals in CML: beyond survival outcomes

Jorge Cortes, MD, Georgia Cancer Center, Augusta University, Augusta, GA, discusses the evolution of

Advancements in CML: improving treatment-free remission and novel agents

Advancements in CML: improving treatment-free remission and novel agents

Jorge Cortes, MD, Georgia Cancer Center, Augusta University, Augusta, GA, discusses exciting

CML: Treatment and Side Effects Tips

CML: Treatment and Side Effects Tips

The fourth video in a series on

The Evolution of CML Treatment and the Push for Better Tolerability – Dr. Andreas Hochhaus

The Evolution of CML Treatment and the Push for Better Tolerability – Dr. Andreas Hochhaus

In this segment, Dr. Andreas Hochhaus, a leading expert in oncology and

Simona Soverini, PhD, on CML Treatment Advances, Remaining Challenges

Simona Soverini, PhD, on CML Treatment Advances, Remaining Challenges

Simona Soverini, PhD, stopped by the Society of Hematologic Oncology booth at the 64th American Society of Hematology ...

Chronic Myeloid Leukemia: Breakthrough Therapies You Should Know

Chronic Myeloid Leukemia: Breakthrough Therapies You Should Know

Medical Centric Recommended : (Affiliate Links) Thermometer ➝ https://amzn.to/48etrFS Blood pressure machine ...

Global Perspectives | Evolution of CML Treatment and Managing Adverse Events

Global Perspectives | Evolution of CML Treatment and Managing Adverse Events

In this webinar, Dr. Jeff Lipton, from the University of Toronto, Canada, Dr. Hemant Malhotra, from Sri Ram Cancer and ...

Current CML treatments: which TKI to choose?

Current CML treatments: which TKI to choose?

Gianantonio Rosti, MD, Institute of Hematology 'Seragnoli', Bologna, Italy, discusses the current landscape of

Chronic Myeloid Leukemia Survivor Shares His Story

Chronic Myeloid Leukemia Survivor Shares His Story

Diagnosed 27 years ago with

iCMLf Conversations: Management of Advanced Phases of CML

iCMLf Conversations: Management of Advanced Phases of CML

Professor Mhairi Copland Professor of Translational Haematology University of Glasgow, UK 00:00 Welcome & Introduction 01:21 ...

Advancing CML and Leukemia Care with TKIs, CAR-T, and AI – Dr. Elias Jabbour

Advancing CML and Leukemia Care with TKIs, CAR-T, and AI – Dr. Elias Jabbour

In this exclusive interview, Dr. Elias Jabbour from MD Anderson Cancer Center shares cutting-edge insights into the evolving ...

Further updates on CML in 2026

Further updates on CML in 2026

... diagnosing

Chronic Myeloid Leukemia: Approaches to Optimizing Care in the Era of TKIs

Chronic Myeloid Leukemia: Approaches to Optimizing Care in the Era of TKIs

Earn CME for related activities: https://www.naccme.com/oln In this webcast from the '

Advancements in Chronic Myeloid Leukemia: Treatment Strategies, Mechanisms, and Patient Management

Advancements in Chronic Myeloid Leukemia: Treatment Strategies, Mechanisms, and Patient Management

Stay current in

Dr. Shah on Frontline Considerations for the Treatment of CML

Dr. Shah on Frontline Considerations for the Treatment of CML

Dr. Shah on Frontline Considerations for the Treatment of CML